Between 2014 and 2017, the company allegedly knowingly caused colorectal and general surgeons to use incorrect codes to obtain inflated reimbursements from Medicare and state Medicaid programs for the use of THD’s hemorrhoid removal system, according to a Sept. 6 news release from the Justice Department.
The removal system was sold to physicians for use in transanal hemorrhoidal dearterialization, according to the release, and THD required physicians to bill for the procedure using a temporary code for new and emerging procedures, which are often denied.
To avoid denials, THD encouraged colorectal and general surgeons to improperly bill Medicare and Medicaid programs using the temporary code plus an additional CPT code or to bill for other CPT codes.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
